Recombinant multi-species SLC33A1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine SLC33A1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene is required for the formation of O-acetylated (Ac) gangliosides. The encoded protein is predicted to contain 6 to 10 transmembrane domains, and a leucine zipper motif in transmembrane domain III. Defects in this gene have been reported to cause spastic paraplegia autosomal dominant type 42 (SPG42) in one Chinese family, but not in similar patients of European descent. Two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2010]
The Alternative Names of target: ACATN,AT-1,AT1,Acatn,Acetyl-CoA transporter 1,Acetyl-coenzyme A transporter 1,CCHLND,D630022N01Rik,HPBDS,SLC33A1,SPG42,Slc33a1,Solute carrier family 33 member 1

Target products collectionGo to SLC33A1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP0002-Ag-1/ GM-Tg-hg-IP0002-Ag-2 Human SLC33A1 protein Human
GM-Tg-rg-IP0002-Ag-1/ GM-Tg-rg-IP0002-Ag-2 Rat SLC33A1 protein Rat
GM-Tg-mg-IP0002-Ag-1/ GM-Tg-mg-IP0002-Ag-2 Mouse SLC33A1 protein Mouse
GM-Tg-cynog-IP0002-Ag-1/ GM-Tg-cynog-IP0002-Ag-2 Cynomolgus/Rhesus macaque SLC33A1 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP0002-Ag-1/ GM-Tg-felg-IP0002-Ag-2 Feline SLC33A1 protein Feline
GM-Tg-cang-IP0002-Ag-1/ GM-Tg-cang-IP0002-Ag-2 Canine SLC33A1 protein Canine
GM-Tg-bovg-IP0002-Ag-1/ GM-Tg-bovg-IP0002-Ag-2 Bovine SLC33A1 protein Bovine
GM-Tg-equg-IP0002-Ag-1/ GM-Tg-equg-IP0002-Ag-2 Equine SLC33A1 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP0002-Ag-1/ GM-Tg-hg-IP0002-Ag-2; GM-Tg-rg-IP0002-Ag-1/ GM-Tg-rg-IP0002-Ag-2;
GM-Tg-mg-IP0002-Ag-1/ GM-Tg-mg-IP0002-Ag-2; GM-Tg-cynog-IP0002-Ag-1/ GM-Tg-cynog-IP0002-Ag-2;
GM-Tg-felg-IP0002-Ag-1/ GM-Tg-felg-IP0002-Ag-2; GM-Tg-cang-IP0002-Ag-1/ GM-Tg-cang-IP0002-Ag-2;
GM-Tg-bovg-IP0002-Ag-1/ GM-Tg-bovg-IP0002-Ag-2; GM-Tg-equg-IP0002-Ag-1/ GM-Tg-equg-IP0002-Ag-2
Products Name SLC33A1 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name SLC33A1
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine SLC33A1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.